FacebookTwitterGoogle+RedditEmail

What Drugs Had Cho Taken?

by FRED GARDNER

Virginia Tech suspended or expelled 32 students last year for illicit drug use, according to Kris Reinertson, a junior who heads the Students for a Sensible Drug Policy chapter. Reinertson doesn’t know how many of the cases involved marijuana.

Virginia Tech applies a double-standard when it comes to alcohol and marijuana, he says. “It’s three strikes for underage drinking and zero tolerance for marijuana possession.” SSDP has been campaigning for a review of the policy. “The Ivy League and many other colleges have a three strikes policy for marijuana,” says Reinertson. “That’s what we want to see on here.”

When we hear about a lethal outburst such as the one at Virginia Tech, millions of Americans wonder whether the perpetrator was on Prozac or some other strong psychotropic drug. Given how readily doctors prescribe antidepressants and stimulants and sedatives and anti-psychotics to anyone presenting with an emotional problem, the odds are very high that Seung-Hoi Cho had been put on one (or more).

The frequency with which SSRIs induce bizarre, violent flip-outs heightens the odds that Cho had been a user. But 10 days after the killings, Cho’s records from the student health center have not been made public and the media is not pressing for their release. We wonder: will university administrators manage to keep Cho’s medical records sealed in the name of privacy or confidentiality or patients’ rights or some other fine-sounding abstraction? Cho’s reputation could not be damaged further, obviously. It’s their reputation (and endowment) they care about.

Pharmaceutical companies pay vast sums to lawyers, lobbyists and public relations firms to deny and evade responsibility for the damage their products cause. Former Congressman Bob Barr is now on the Big Pharma payroll. He weighed in with a syndicated column last week- ” ‘Ambien’ Defense Causing Headaches for Prosecutors”- that used Virginia Tech as a hook, took a shot at gun-control advocates, and sought to exonerate the makers of whatever drugs Cho or any other deranged person may have been on at the time of their flip-out.

“Barely had Seung-Hui Cho completed his carnage by taking his own wretched life, than those seeking to divert focus from the tortured mind of a mentally deranged young man were declaring that responsibility for the carnage lay not with the individual who perpetrated it, but rather with the system that gave him the tools by which he chose to carry out his deeds While the methods employed by trial lawyers through which this latest defense theory is raised are many, the primary vehicle of choice appears to be the popular sleep medication, Ambien; largely, no doubt, as a result of the market share enjoyed by this drug.”

Ambien is a sleeping pill that last year generated about $2.3 billion for its manufacturer, Sanfoi-Aventis. U.S. doctors wrote some 27.6 million prescriptions for Ambien in 2006, out of 44 million scripts for all sleeping pills. Lunesta, whose ads feature a moth on the verge of extinction, is second with 5.8 million scripts.

Sanofi is being sued by thousands of Ambien users who, while sleeping, engaged in various activities -eating, driving making purchases over the internet- which they did not recall upon waking. Sanofi’s prescribing information had noted, merely, “Somnambulism is a possible rare adverse event.” But somnambulism is a reflex, frying some eggs or driving is complex behavior.

In March the FDA instructed Sanofi et al to strengthen the warnings on their labels and recommended -not required- that they conduct additional clinical studies into sleep-driving, etc.

Bob Barr’s convoluted column is part of the sleeping-pill manufacturers’ counter-thrust. He goes on:

“The pharmaceutical companies that manufacture these medications include on their Web sites, in their advertising and in printed materials accompanying the products, detailed warnings about potential side effects and misuse of the drug. The companies and their products are tightly regulated by the federal Food and Drug Administration. In fact, just one month ago, the FDA urged the companies to include expanded warnings with the prescriptions. Key among the listed contraindications for the drugs is the necessity to use them only with a full night’s sleep, and to avoid any drinking of alcohol before or after taking the pills; but the medications continue to be abused. One well-known trial lawyer in Georgia, William C. Head, for example, noted that in the overwhelming majority of cases in which sleep-disorder drugs are involved, the person consumed alcohol. Still, the efforts to raise the specter of the drugs absolving the user of criminal or civil responsibility continue.”

“History has shown that permitting such defenses as the so-called ‘Ambien defense’ to be viewed as legitimate, especially if accompanied by just a few instances in which the tactic is successful in court — as happened recently in an Austin, Texas, Driving While Intoxicated case — will quickly become pervasive and lead to increased irresponsible, possibly criminal, behavior.

“We have no way of knowing in what contexts the Ambien defense or its progeny will rear its ugly head in the years and decades to come, if it is allowed to take hold. What we do know, even now as the defense is just starting to develop, is that teens and adults alike are modifying their behavior — taking medications that have legitimate but serious effects, for the wrong reasons and under improper circumstances, then posing a danger to themselves and others — based on the possibility that they will not be held accountable for the results of their actions. This is a danger none of us can afford.”

Barr has been hired as a lobbyist by the Marijuana Policy Project.

Last week we noted the poignant juxtaposition of the Virginia Tech story and coverage of a study in the Journal of the American Medical Association advocating a weaker warning on the Prozac label regarding suicidal ideation. That same issue of JAMA, April 18, contained a study showing that for-profit dialysis chains give patients much higher doses of Epogen than non-profit clinics. Epogen, made by Amgen Inc., is a synthetic version of a hormone that stimulates the production of red blood cells. During dialysis it is added to the blood as toxins are removed.

The for-profit dialysis chains get a quarter of their income from the sale of Epogen -plus rebates from Amgen based on how much product they move. Investigators from the Medical Technology and Practice Patterns Institute looked at 134,000 patients treated in 2004.

Some patients at for-profit clinics were found to be getting three times more Epogen than their counterparts at non-profits. “It’s clear there is a profit incentive,” says co-author Dennis Cotter.

FRED GARDNER edits O’Shaughnessy’s, the Journal of Cannabis in Clinical Practice (soon to have a presence on the web). He can be reached at fred@plebesite.com

 

Fred Gardner is the managing editor of O’Shaughnessy’s. He can be reached at fred@plebesite.com

May 04, 2016
CJ Hopkins
Coming this Summer … Revenge of the Bride of Sophie’s Choice
May 03, 2016
Gary Leupp
Hillary Clinton’s Foreign Policy Resumé: What the Record Shows
Michèle Brand – Arun Gupta
What is the “Nuit Debout”?
Chuck Churchill
The Failures of Capitalism, Donald Trump and Right Wing Terror
Dave Marsh
Bernie and the Greens
John Wight
Zionism Should be on Trial, Not Ken Livingstone
Rev. John Dear
A Dweller in Peace: the Life and Times of Daniel Berrigan
Patrick Cockburn
Saudi Arabia’s Great Leap Forward: What Would Mao Think?
Doug Johnson Hatlem
Electoral Votes Matter: Hillary Clinton or Bernie Sanders vs Donald Trump
Chris Gilbert
Venezuela Today: This Must Be Progress
Pepe Escobar
The Calm Before the Coming Global Storm
Ruth Fowler
Intersecting with the Identity Police (Or Why I Stopped Writing Op-Eds)
Victor Lasa
The Battle Rages on in Spain: the Country Prepares for Repeat Elections in June
Jack Rasmus
Is the US Economy Heading for Recession?
Dean Baker
Time for an Accountable Federal Reserve
Ted Rall
Working for US Gov Means Never Saying Sorry
Dave Welsh
Hunger Strikers at Mission Police Station: “Stop the execution of our people”
John Eskow
The Death of Prince and the Death of Lonnie Mack
May 02, 2016
Michael Hudson – Gordon Long
Wall Street Has Taken Over the Economy and is Draining It
Paul Street
The Bernie Fade Begins
Ron Jacobs
On the Frontlines of Peace: the Life of Daniel Berrigan
Louis Yako
Dubai Transit
Bill Quigley
Teacher, Union Leader, Labor Lawyer: Profile of Chris Williams Social Justice Advocate
Patrick Cockburn
Into the Green Zone: Iraq’s Disintegrating Political System
Lawrence Ware
Trump is the Presidential Candidate the Republicans Deserve
Ron Forthofer
Just Say No to Corporate Rule
Ralph Nader
The Long-Distance Rebound of Bernie Sanders
Ken Butigan
Remembering Daniel Berrigan, with Gratitude
Nicolas J S Davies
Escalating U.S. Air Strikes Kill Hundreds of Civilians in Mosul, Iraq
Binoy Kampmark
Class, Football, and Blame: the Hillsborough Disaster Inquest
George Wuerthner
The Economic Value of Yellowstone National Park
Rivera Sun
Celebrating Mother Jones
Nyla Ali Khan
Kashmir and Postcolonialism
Mairead Maguire
Drop the Just War Theory
Weekend Edition
April 29, 2016
Friday - Sunday
Andrew Levine
What is the Democratic Party Good For? Absolutely Nothing
Roberto J. González – David Price
Anthropologists Marshalling History: the American Anthropological Association’s Vote on the Academic Boycott of Israeli Institutions
Robert Jacobs
Hanford, Not Fukushima, is the Big Radiological Threat to the West Coast
Ismael Hossein-Zadeh
US Presidential Election: Beyond Lesser Evilism
Dave Lindorff
The Push to Make Sanders the Green Party’s Candidate
Peter Linebaugh
Marymount, Haymarket, Marikana: a Brief Note Towards ‘Completing’ May Day
Ian Fairlie
Chernobyl’s Ongoing Toll: 40,000 More Cancer Deaths?
Pete Dolack
Verizon Sticks it to its Workers Because $45 Billion isn’t Enough
Moshe Adler
May Day: a Trade Agreement to Unite Third World and American Workers
Margaret Kimberley
Dishonoring Harriet Tubman
Deepak Tripathi
The United States, Britain and the European Union
FacebookTwitterGoogle+RedditEmail